JPRN-jRCT2031210589进行中（未招募）未知
A special drug use-results survey to evaluate the safety and efficacy of subcutaneous administration of Cosentyx in pediatric patients with psoriasis vulgaris, psoriatic arthritis, or pustular psoriasis
Toshiya Sugimoto0 个研究点目标入组 35 人开始时间: 2022年1月31日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 < 18age old（—）
- 性别
- All
入选标准
- •1.Patients who have obtained written consent from their legally acceptable representative to cooperate in this survey before the start of treatment with this drug
- •2.Patients aged less than 18 years at the start of treatment with this drug
- •3.Patients newly treated with this drug for any of the following diseases: Psoriasis vulgaris, psoriatic arthritis, pustular psoriasis
排除标准
- •1.Prior treatment with this drug
- •2.Participation in an interventional study (e.g., a clinical trial) at the time of starting this drug.
研究者
相似试验
招募中
Unknown
Special Drug Use-Results Survey (All-Case Surveillance) to Investigate Safety and Effectiveness in Patients with Paroxysmal Nocturnal Hemoglobinuria Who Received Empaveli in the Post-Marketing Clinical Use in JapaParoxysmal nocturnal hemoglobinuriaJPRN-jRCT2031230275Shimmoto Naoki100
招募中
不适用
Special Drug Use Results Survey for the use of Symtuza in pregnant womeJPRN-UMIN000037488Janssen Pharmaceutical K.K.3
已完成
不适用
Special Drug Use-Results Survey for Long-term Use of XEPLION TRI Aqueous Suspension for IM Injection 175 mg, 263 mg, 350 mg, and 525 mg SyringeSchizophreniaJPRN-UMIN000042033Janssen Pharma990
已完成
不适用
Specified Drug Use-Results Survey on "long-term use for Nouriast Tablet "s diseaseParkinson's diseaseJPRN-UMIN000030014Kyowa Hakko Kirin Co., Ltd.1,000
尚未招募
不适用
Evaluation Of Drug Usage In Cardiac PatientsCTRI/2021/01/030356il